Total Payments
$1,355
2024 Payments
$660.77
Companies
15
Transactions
48
Medicare Patients
294
Medicare Billing
$24,374
Payment Breakdown by Category
Food & Beverage$1,116 (82.4%)
Education$238.97 (17.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,116 | 45 | 82.4% |
| Education | $238.97 | 3 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $375.48 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $269.29 | 4 | $0 (2024) |
| ABBVIE INC. | $190.76 | 7 | $0 (2022) |
| Gilead Sciences, Inc. | $122.19 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $121.52 | 1 | $0 (2022) |
| PFIZER INC. | $38.89 | 2 | $0 (2023) |
| Stemline Therapeutics Inc. | $37.89 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $34.32 | 1 | $0 (2023) |
| Deciphera Pharmaceuticals Inc. | $30.91 | 1 | $0 (2023) |
| GENZYME CORPORATION | $30.87 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.77 | 20 | Astellas Pharma US Inc ($269.29) |
| 2023 | $143.60 | 7 | Novartis Pharmaceuticals Corporation ($43.32) |
| 2022 | $428.29 | 18 | AstraZeneca Pharmaceuticals LP ($121.52) |
| 2021 | $122.53 | 3 | AbbVie Inc. ($122.53) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 10/31/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.00 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Oncology | ||||||
| 07/30/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Oncology | ||||||
| 03/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $93.00 | General |
| 03/07/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: ONC | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Oncology | ||||||
| 01/08/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Oncology | ||||||
| 08/04/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 04/14/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 143 | 219 | $69,602 | $13,159 |
| 2022 | 2 | 135 | 175 | $59,680 | $11,158 |
| 2020 | 1 | 16 | 19 | $380.00 | $56.82 |
Total Patients
294
Total Services
413
Medicare Billing
$24,374
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 123 | $67,650 | $12,353 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 96 | $1,952 | $806.40 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 106 | $58,300 | $10,954 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 54 | 69 | $1,380 | $204.30 | 14.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 16 | 19 | $380.00 | $56.82 | 15.0% |
About Casey Chambers
Casey Chambers is a Adult Health healthcare provider based in Greenlawn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1770026601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Chambers has received a total of $1,355 in payments from pharmaceutical and medical device companies, with $660.77 received in 2024. These payments were reported across 48 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,116).
As a Medicare-enrolled provider, Chambers has provided services to 294 Medicare beneficiaries, totaling 413 services with total Medicare billing of $24,374. Data is available for 3 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Greenlawn, NY
- Active Since 11/25/2016
- Last Updated 06/28/2023
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1770026601
Products in Payments
- KISQALI (Drug) $324.76
- Trodelvy (Drug) $122.19
- ENHERTU (Biological) $121.52
- CREON (Drug) $101.82
- PIQRAY (Drug) $50.72
- Orserdu (Drug) $37.89
- KEYTRUDA (Biological) $34.32
- QINLOCK (Drug) $30.91
- ELITEK (Biological) $30.87
- Xospata (Drug) $30.32
- REZUROCK (Drug) $26.45
- DARZALEX (Biological) $23.53
- BOSULIF (Drug) $23.48
- KRAZATI (Drug) $19.64
- DOPTELET (Drug) $18.23
- XTANDI (Drug) $15.41
- POTELIGEO (Drug) $15.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.